FDA reveals further steps to encourage generic competition

03-01-2018

FDA reveals further steps to encourage generic competition

carmendorin / iStockphoto.com

The US Food and Drug Administration (FDA) revealed additional steps aimed at encouraging generic competition today.


Food and Drug Administration, FDA, Scott Gottlieb, generics, competition, drug pricing, ANDA

LSIPR